Material Agreements

enGene Therapeutics Inc. entered into Sales Agreement with Leerink Partners LLC valued at up to $100,000,000 (effective 2026-03-09).

“On March 9, 2026, enGene Holdings Inc. (the “Company”) entered into a sales agreement (the “Sales Agreement”) with Leerink Partners LLC (“Leerink Partners”), pursuant to which the Company may sell its common shares, without par value (the “Common Shares”), from time to time through Leerink Partners.”

Aureus Greenway Holdings Inc entered into Agreement and Plan of Merger with Autonomous Power Corporation (effective 2026-03-08).

“On March 8, 2026, Aureus Greenway Holdings Inc., a Nevada corporation (“ Parent ” or the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) by and among Parent, Aureus Merger Sub Inc., a Delaware corporation and direct wholly owned subsidiary of Parent (“ Merger Sub ”), Autonomous Power Corporation, a Delaware corporation (“ Target ”), and Andrew Fox, solely in his capacity as the representative, agent and attorney-in-fact of the stockholders of Target (the “ Stockholder Representative ”).”

Calisa Acquisition Corp entered into Business Combination Agreement with Goodvision AI Inc. valued at Calisa Acquisition Corp (SPAC) will acquire Goodvision AI Inc. via merger; Goodvision shareholders r (effective 2026-03-06).

“On March 6, 2026 (the “ Execution Date ”), Calisa Acquisition Corp, a Cayman Islands exempted company (the “ Company ”), entered into an Business Combination Agreement (the “ BCA ”) with Calisa Merger Sub, a Cayman Islands exempted company and a direct, wholly owned subsidiary of the Company (“ Merger Sub ”), and Goodvision AI Inc., a Cayman Islands exempted company (“ Goodvision ”).”

Ribbon Acquisition Corp. entered into Note with Ribbon Investment Company Ltd valued at $600,000 (effective 2026-03-07).

“On March 7, 2026, Ribbon Acquisition Corp. (the “Company”) issued a promissory note (the “Note”) in the principal amount of $600,000 to Ribbon Investment Company Ltd, a shareholder of the Company’s sponsor (the “Payee”).”

MiniMed Group, Inc. entered into Transition Services Agreement with Medtronic plc.

“• Transition Services Agreement, pursuant to which Medtronic provides to the Company and the Company provides to Medtronic certain services for a limited period of time following the completion of the Separation.”

MiniMed Group, Inc. entered into Registration Rights Agreement with Medtronic plc.

“• Registration Rights Agreement, pursuant to which the Company has granted Medtronic certain registration rights with respect to the shares of Common Stock owned by Medtronic following the completion of the IPO.”

MiniMed Group, Inc. entered into Tax Matters Agreement with Medtronic plc.

“• Tax Matters Agreement, which governs the Company and Medtronic’s respective rights, responsibilities, and obligations with respect to tax matters, including tax liabilities (including responsibility and potential indemnification obligations for taxes attributable to the Company’s business and taxes arising, under certain circumstances, in connection with the Separation and the Divestment, if pursued), tax attributes, tax contests, and tax returns.”

MiniMed Group, Inc. entered into merger agreement with Kangaroo US HoldCo 2, Inc. (effective 2026-03-05).

“On March 5, 2026, the Company entered into a merger agreement with KH2 and KH2 merged with and into the Company, with the Company surviving the merger.”

MiniMed Group, Inc. entered into Separation Agreement with Medtronic plc.

“• Separation Agreement, which sets forth the Company’s agreements with Medtronic regarding the principal actions to be taken in connection with the Separation and governs, among other matters, (1) the allocation of assets and liabilities to the Company and Medtronic (including the Company’s indemnification obligations, for potentially uncapped amounts, for certain liabilities relating to the Company’s business activities, whether incurred prior to or following the completion of the IPO) and (2) certain matters with respect to the IPO and Medtronic’s intended tax-free distribution to its shareholders of all or a portion of its remaining equity interest in the Company (such distribution, the “ Divestment ”).”

AtaiBeckley Inc. terminated Open Market Sale Agreement with Jefferies LLC (effective 2026-03-06).

“Also on March 6, 2026, the Company and Jefferies terminated the Open Market Sale Agreement SM dated as of November 10, 2022, by and between the Company and Jefferies.”

AtaiBeckley Inc. entered into Open Market Sale Agreement with Jefferies LLC (effective 2026-03-06).

“On March 6, 2026, AtaiBeckley Inc. (the “Company”) entered into an Open Market Sale Agreement SM (the “Sales Agreement”) with Jefferies LLC (“Jefferies”), pursuant to which the Company may issue and sell its common stock, par value $0.01 per share (the “Common Stock”), from time to time through an “at the market” equity offering program”

PRESIDIO PRODUCTION Co entered into Credit Agreement with Citizens Bank, N.A., as administrative agent, and the lenders from time to time party thereto valued at $65.0 million (effective 2026-03-04).

“On March 4, 2026, Presidio Borrower LLC, a wholly owned subsidiary of the Company (“Presidio Borrower”), entered into a senior secured revolving credit agreement (the “Credit Agreement”) among Presidio Borrower, as borrower, Citizens Bank, N.A., as administrative agent, and the lenders from time to time party thereto.”

PRESIDIO PRODUCTION Co entered into Warrant Agreement Amendment and Assignment with EQV and Continental Stock Transfer & Trust Company.

“On the Closing Date, the Company entered into the Assignment, Assumption and Amendment Agreement (the “Warrant Agreement Amendment and Assignment”), by and among the Company, EQV and Continental Stock Transfer & Trust Company (“Continental”).”

PRESIDIO PRODUCTION Co entered into A&R LLC Agreement with EQV Holdings.

“On the Closing Date, in connection with the Business Combination, EQV Holdings’ existing limited liability company agreement was amended and restated (the “A&R LLC Agreement”)”

PRESIDIO PRODUCTION Co entered into Registration and Stockholders' Rights Agreement with EQVR Intermediate, certain equityholders of PIH, certain members of the Company’s management and the Sponsor (collectively, the "Registration Rights Parties"), EQV, EQV Holdings.

“On the Closing Date, in connection with the Business Combination, EQVR Intermediate, certain equityholders of PIH, certain members of the Company’s management and the Sponsor (collectively, the “Registration Rights Parties”), EQV, EQV Holdings, and the Company entered into a registration and stockholders’ rights agreement (the “Registration and Stockholders’ Rights Agreement”).”

LISATA THERAPEUTICS, INC. entered into Agreement and Plan of Merger with Kuva Labs Inc. (effective 2026-03-06).

“On March 6, 2026, Lisata Therapeutics, Inc., a Delaware corporation (the “Company” or “Lisata”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Kuva Labs Inc., a Delaware corporation (“Parent”), and Kuva Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”).”

NIKE, Inc. terminated Prior 364‐Day Credit Agreement with the banks, financial institutions and other lenders signatory thereto valued at up to $1.0 billion (effective 2026-03-06).

“On March 6, 2026, concurrently with the Company’s entry into the 364-Day Credit Agreement described in Item 1.01 hereof, the Company terminated the existing Credit Agreement dated March 7, 2025, which provided for up to $1.0 billion of borrowings in U.S. Dollars pursuant to a 364‐day unsecured revolving credit facility, with the banks, financial institutions and other lenders signatory thereto (the “Prior 364‐Day Credit Agreement”).”

NIKE, Inc. entered into 364‐Day Credit Agreement with Bank of America, N.A., as administrative agent, and the other financial institutions named therein as lenders valued at up to $1 billion (effective 2026-03-06).

“On March 6, 2026, NIKE, Inc. (the “Company”) entered into a 364-Day Credit Agreement with Bank of America, N.A., as administrative agent, and the other financial institutions named therein as lenders (the “364‐Day Credit Agreement”). The 364‐Day Credit Agreement provides for up to $1 billion of borrowings”

ALEXANDERS INC entered into Agreement of Purchase and Sale with Northwell Health, Inc. valued at $235.5 million (effective 2026-03-06).

“On March 6, 2026 , Alexander’s Rego Shopping Center LLC, a wholly-owned subsidiary of Alexander’s, Inc. (the “Company”), entered into an Agreement of Purchase and Sale (the “Agreement”) with Northwell Health, Inc. (“Northwell”) to sell its Rego Park I shopping center (“Rego Park I”) located in Queens to Northwell for $235.5 million in cash payable upon closing.”

AIR T INC entered into Share Purchase Agreement with Arena Aviation Partners B.V. valued at in excess of 35 million (effective 2026-03-08).

“On March 8, 2026, Air T, Inc. (the “Company”), through Crestone Air Partners LLC (the “Purchaser” or “Crestone”), entered into a Share Purchase Agreement (the “Purchase Agreement”) with Arena Aviation Partners B.V. (“Arena”), the sellers party thereto (collectively, the “Sellers”), and Dirk Jan Smit, as Securityholders’ Agent, pursuant to which Purchaser agreed to acquire all of the outstanding shares of Arena.”

AMERICAN AIRLINES, INC. amended Fourth Amendment with Citibank, N.A., as administrative agent, and the lenders valued at incremental revolving credit commitments of $1,451.3 million (effective 2026-03-05).

“Additionally, on March 5, 2026, the Company and AAG entered into the Fourth Amendment to Credit and Guaranty Agreement (the “Fourth Amendment”), amending the Credit and Guaranty Agreement, dated as of December 4, 2023 (as amended or amended and restated prior to the Fourth Amendment, the “Prior 2023 Credit Agreement” and, as amended by the Fourth Amendment, the “2023 Credit Agreement”), by and among the Company, AAG, the lenders party thereto and Citibank, N.A., as administrative agent.”

AMERICAN AIRLINES, INC. amended 2013 Eleventh Amendment with Barclays Bank PLC, as administrative agent, and the lenders valued at incremental revolving credit commitments of $362.8 million and new letter of credit commitments of $ (effective 2026-03-05).

“Also on March 5, 2026, the Company and AAG entered into the Eleventh Amendment to Amended and Restated Credit and Guaranty Agreement (the “2013 Eleventh Amendment”), amending the Amended and Restated Credit and Guaranty Agreement, dated as of May 21, 2015 (as amended or amended and restated prior to the 2013 Eleventh Amendment, the “Prior 2013 Credit Agreement” and, as amended by the 2013 Eleventh Amendment, the “2013 Credit Agreement”), by and among the Company, AAG, the lenders party thereto, the issuing lenders party thereto and Barclays Bank PLC, as administrative agent.”

AMERICAN AIRLINES, INC. amended 2014 Eleventh Amendment with Citibank, N.A., as administrative agent, and the lenders valued at incremental revolving credit commitments of $1,295.8 million and new letter of credit commitments of (effective 2026-03-05).

“On March 5, 2026, the Company and AAG entered into the Eleventh Amendment to Amended and Restated Credit and Guaranty Agreement (the “2014 Eleventh Amendment”), amending the Amended and Restated Credit and Guaranty Agreement, dated as of April 20, 2015 (as amended or amended and restated prior to the 2014 Eleventh Amendment, the “Prior 2014 Credit Agreement” and, as amended by the 2014 Eleventh Amendment, the “2014 Credit Agreement”), by and among the Company, AAG, the lenders party thereto, the issuing lenders party thereto and Citibank, N.A., as administrative agent.”

HUMANA INC entered into First Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. (effective 2026-03-09).

“as supplemented by a first supplemental indenture, dated as of March 9, 2026, by and between the Company and the Trustee relating to the Subordinated Notes (the “First Supplemental Indenture””

HUMANA INC entered into Original Indenture with The Bank of New York Mellon Trust Company, N.A. (effective 2026-03-05).

“The Subordinated Notes were issued under an amended and restated indenture dated as of March 5, 2026, by and between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”) (the “Original Indenture")”

HUMANA INC entered into Underwriting Agreement with Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC valued at $1.0 billion (effective 2026-03-05).

“On March 5, 2026, Humana Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters (together, the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters $1.0 billion aggregate principal amount of its 6.625% Fixed-to-Fixed Rate Junior Subordinated Notes due 2056”

MARZETTI CO amended First Amendment to Credit Agreement with The Huntington National Bank, Bank of America, N.A., JPMorgan Chase Bank, N.A., and the other lenders named therein valued at $200 million term loan (effective 2026-03-04).

“The Amendment provides for an increase to the revolving loan from $150 million to $200 million, and for an additional $200 million term loan”

SELECTIS HEALTH, INC. entered into Operations Transfer Agreement with Abbeville Crossing of Journey LLC and Eastman Trails of Journey LLC (effective 2026-03-05).

“Concurrently with the execution of the PSA, the Company caused the Existing Operators to execute an Operations Transfer Agreement (“ OTA ”) with two newly formed entities affiliated with the Purchasers, Abbeville Crossing of Journey LLC and Eastman Trails of Journey LLC, each a Georgia limited liability company (each a “ New Operator ”)”

SELECTIS HEALTH, INC. entered into Purchase and Sale Agreement with Abbeville Crossing Propco of Journey LLC and Eastman Trails Propco of Journey LLC valued at $15,700,000.00 (effective 2026-03-05).

“Effective on March 5, 2026, Selectis Health, Inc., a Utah corporation (the “ Company ”) caused two of the Company’s wholly-owned subsidiaries Global Abbeville Property, LLC and Dodge NH, LLC , each a Georgia limited liability company (each a “ Seller ”) to execute and deliver a definitive Purchase and Sale Agreement (“ PSA ”) with two newly formed entities: Abbeville Crossing Propco of Journey LLC and Eastman Trails Propco of Journey LLC, each a Georgia limited liability company (each a “ Purchaser ”)”

Essential Utilities, Inc. entered into Tenth Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $500,000,000 principal amount (effective 2026-03-09).

“On March 9, 2026, Essential Utilities, Inc. (the “Company”) issued $500,000,000 principal amount of its 5.125% Senior Notes due 2036 (the “Notes”).”

SM Energy Co entered into Indenture for 6.625% Senior Notes due 2034 with U.S. Bank Trust Company, National Association valued at $1,000,000,000 aggregate principal amount of 6.625% Senior Notes due 2034; maturity April 15, 2034; (effective 2026-03-09).

“On March 9, 2026, the Company entered into the Indenture relating to the Notes (the “ Indenture ”), with the guarantors party thereto and U.S. Bank Trust Company, National Association, a national banking association, as trustee (the “ Trustee ”), governing the Notes.”

SM Energy Co entered into Purchase Agreement for 6.625% Senior Notes due 2034 with BofA Securities, Inc. valued at $1,000,000,000 aggregate principal amount of 6.625% Senior Notes due 2034 (effective 2026-03-04).

“On March 9, 2026, SM Energy Company (the “ Company ”) issued and sold $1.0 billion in aggregate principal amount of the Company’s 6.625% Senior Notes due 2034 (the “ Notes ”), pursuant to a Purchase Agreement, dated March 4, 2026, among the Company, the guarantors party thereto (the “ Subsidiary Guarantors ”) and BofA Securities, Inc., acting as representative of the several initial purchasers named therein (the “ Initial Purchasers ”).”

SL GREEN REALTY CORP amended Thirty-Second Amendment with SL Green Operating Partnership, L.P. (effective 2026-03-04).

“On March 4, 2026, SL Green Realty Corp. (the “Company”), as the general partner of SL Green Operating Partnership, L.P. (the “Operating Partnership”), entered into a thirty-second amendment (the “Thirty-Second Amendment”) to the Operating Partnership’s First Amended and Restated Agreement of Limited Partnership, dated August 20, 1997”

Modular Medical, Inc. entered into Placement Agency Agreement with Maxim Group LLC valued at cash fee equal to 7% of the gross proceeds (effective 2026-03-03).

“On March 3, 2026, Modular Medical, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC (the “Placement Agent”) and securities purchase agreements (the “Securities Purchase Agreements”) with multiple investors, relating to a best-efforts offering (the “Offering”) of (i) 62,098,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), (ii) pre-funded warrants (the “pre-funded warrants”) to purchase 6,000,000 shares of Common Stock, and (iii) accompanying warrants exercisable to purchase up to 68,098,000 shares of Common Stock (the “common warrants”). The Company received gross proceeds of approximately $12 million from the Offering, before deducting placement agent fees and offering expenses. Pursuant to the Placement Agency Agreement, the Company paid the Placement Agent a cash fee equal to 7% of the gross proceeds received from the Offering and reimbursed the Placement Agent for its expe”

Modular Medical, Inc. entered into Securities Purchase Agreements with multiple investors valued at gross proceeds of approximately $12 million (effective 2026-03-03).

“On March 3, 2026, Modular Medical, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC (the “Placement Agent”) and securities purchase agreements (the “Securities Purchase Agreements”) with multiple investors, relating to a best-efforts offering (the “Offering”) of (i) 62,098,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), (ii) pre-funded warrants (the “pre-funded warrants”) to purchase 6,000,000 shares of Common Stock, and (iii) accompanying warrants exercisable to purchase up to 68,098,000 shares of Common Stock (the “common warrants”). The Company received gross proceeds of approximately $12 million from the Offering, before deducting placement agent fees and offering expenses.”

DYADIC INTERNATIONAL INC entered into At-The-Market Issuance Sales Agreement with Craig-Hallum Capital Group LLC valued at up to $4,237,818 (effective 2026-03-06).

“On March 6, 2026, Dyadic International, Inc. (the “Company”) entered into an At-The-Market Issuance Sales Agreement (the “Sales Agreement”) with Craig-Hallum Capital Group LLC, as sales agent (the “Sales Agent”), pursuant to which the Company may offer and sell from time to time, at its option, shares of the Company’s common stock having an aggregate offering price of up to $4,237,818”

Amphastar Pharmaceuticals, Inc. amended Contract Research Amendment with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. valued at approximately $0.6 million (effective 2026-03-03).

“On March 3, 2026 (the “Effective Date”), Amphastar Pharmaceuticals, Inc (“Amphastar” or, the “Company”) and Nanjing Hanxin Pharmaceutical Technology Co., Ltd. (“Hanxin”) entered into an amendment (the “Contract Research Amendment”) to the Contract Research Agreement (the “Contract Research Agreement”), originally entered into on September 15, 2025, as previously reported by the Company on a Current Report on Form 8-K filed on September 18, 2025.”

Amphastar Pharmaceuticals, Inc. entered into Supply Agreement with Nanjing Letop Biotechnology Co., Ltd. (effective 2026-03-03).

“On March 3, 2026, (the “Effective Date”), Amphastar Nanjing Pharmaceuticals, Inc. (“ANP”), the Chinese subsidiary of Amphastar Pharmaceuticals, Inc. (“Amphastar” or, the “Company”), entered into a supply agreement (the “Supply Agreement”) with Nanjing Letop Biotechnology Co., Ltd. (“Letop”).”

Waste Connections, Inc. entered into Underwriting Agreement with BofA Securities, Inc., J.P. Morgan Securities LLC, PNC Capital Markets LLC and Truist Securities, Inc., as representatives of the several underwriters named therein valued at $600 million aggregate principal amount (effective 2026-03-05).

“On March 5, 2026, Waste Connections, Inc. (“Waste Connections” or the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with BofA Securities, Inc., J.P. Morgan Securities LLC, PNC Capital Markets LLC and Truist Securities, Inc., as representatives of the several underwriters named therein (collectively, the “Underwriters”), relating to the public offering (the “Offering”) by Waste Connections of $600 million aggregate principal amount of its 4.800% Senior Notes due 2036 (the “Notes”).”

Duke Energy CORP entered into Equity Distribution Agreement with multiple financial institutions acting as sales agents and forward purchasers valued at up to an aggregate sales price of $6,000,000,000 (effective 2026-03-06).

“nergy Corporation (the “Company”) entered into an Equity Distribution Agreement dated March 6, 2026 (the “Equity Distribution Agreement”) with Barclays Capital Inc., BMO Capital Markets Corp., BNY Mellon Capital Markets, LLC, BofA Securities, Inc.,”

AMC ENTERTAINMENT HOLDINGS, INC. entered into Commitment Letter with Deutsche Bank AG New York Branch valued at $425,000,000 (effective 2026-03-06).

“On March 6, 2026, AMC Entertainment Holdings, Inc. (the “Company,” or “AMC”), together with its wholly-owned subsidiary Odeon Finco PLC (“Odeon”), entered into a commitment letter (the “Commitment Letter”) with Deutsche Bank AG New York Branch (the “Lender”) providing for a new senior secured credit facility of Odeon in an aggregate principal amount of up to $425,000,000 (the “Odeon Credit Facility”).”

HIGH WIRE NETWORKS, INC. entered into Global Settlement and Mutual Release Agreement with Thoth Aerospace Inc., Dennis O’Leary, Mark W. Porter valued at Aggregate settlement amount of $150,000 payable in installments equal to 5% of gross proceeds from e (effective 2026-03-03).

“On March 3, 2026, in connection with the transactions contemplated by the Agreement, the Company, Thoth, the Selling Shareholder, and Mark W. Porter entered into a Global Settlement and Mutual Release Agreement (the “Settlement Agreement”).”

HIGH WIRE NETWORKS, INC. entered into Securities Exchange Agreement with Thoth Aerospace Inc. valued at Issuance of 16,597,353 shares of common stock (80% of fully diluted shares) in exchange for all Thot (effective 2026-03-03).

“On March 3, 2026, High Wire Networks, Inc., a Nevada corporation (the “ Company ”), entered into a Securities Exchange Agreement (the “ Agreement ”) with Thoth Aerospace Inc., a New York corporation (“ Thoth ”), Dennis O’Leary, the sole shareholder of Thoth (the “ Selling Shareholder ”), and Mark W. Porter, the Company’s sole officer and director and a holder of shares of the Company’s Series B Preferred Stock.”

Spirit Aviation Holdings, Inc. entered into Consent and Waiver with certain beneficial and record holders of the Company's common stock and warrants (effective 2026-03-05).

“On March 5, 2026, Spirit Aviation Holdings, Inc. (the “Company”) and certain beneficial and record holders (the “Holders”) of the shares of common stock of the Company (the “Common Stock”) and the warrants of the Company entered into a consent and waiver (the “Consent and Waiver”) to that certain Registration Rights Agreement, dated as of March 12, 2025 (the “Registration Rights Agreement”).”

MacKenzie Realty Capital, Inc. entered into Note Purchase Agreement with Streeterville Capital, LLC valued at $1,095,000 (effective 2026-03-06).

“On March 6, 2026, MacKenzie Realty Capital, Inc. (the “Company”) entered into a Note Purchase Agreement (the “Note Purchase Agreement”) by and between the Company and Streeterville Capital, LLC (the “Investor”).”

AMERICAN REBEL HOLDINGS INC entered into Exchange Agreements with Streeterville Capital, LLC (effective 2026-02-25).

“reviously disclosed, on June 26, 2025, the Company entered into a note purchase agreement with Streeterville Capital, LLC (“Streeterville”) pursuant to which the Company issued and sold to Streeterville a secured promissory note in the original principal amount of $5,470,000.”

Medalist Diversified, Inc. entered into Purchase and Sale Agreement with HPX Goldsboro Ashley Center LLC valued at $16,600,000 (effective 2026-03-05).

“On March 5, 2026, (the “Effective Date”), MDR Ashley Plaza, LLC, a Delaware limited liability company (the “Seller”), entered into a Purchase and Sale Agreement (the “Purchase and Sale Agreement”), with HPX Goldsboro Ashley Center LLC, a Delaware limited liability company (the “Purchaser”), whereby the Purchaser agreed to acquire (the “Acquisition”) a 156,012 square foot retail property located at 201–221 North Berkeley Boulevard in Goldsboro, North Carolina (the “Ashley Plaza Property”).”

Alzamend Neuro, Inc. entered into At-the-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC valued at up to $3.0 million (effective 2026-03-06).

“On March 6, 2026, Alzamend Neuro, Inc. (the “ Company ”) entered into an At-the-Market Issuance Sales Agreement (the “ Sales Agreement ”) with Ascendiant Capital Markets, LLC, as sales agent (the “ Agent ”) to sell shares of its common stock, par value $0.0001 (the “ Common Stock ”), having an aggregate offering price of up to $3.0 million (the “ Shares ”) from time to time, through an “at the market offering””

CANADIAN PACIFIC KANSAS CITY LTD/CN entered into Eighth Supplemental Indenture with Computershare Trust Company N.A. (effective 2026-03-06).

“The Securities were issued pursuant to an Indenture, dated as of September 11, 2015, by the Company and Computershare Trust Company N.A., as successor to Wells Fargo Bank, National Association, as trustee (the “Trustee”), as supplemented by the Eighth Supplemental Indenture, dated as of March 6, 2026 (the “Eighth Supplemental Indenture”), by and among the Company, the Guarantor and the Trustee.”

CANADIAN PACIFIC KANSAS CITY LTD/CN entered into Underwriting Agreement with Goldman Sachs & Co. LLC, Barclays Capital Inc., Citigroup Global Markets Inc. and SMBC Nikko Securities America, Inc. (effective 2026-03-04).

“on March 4, 2026, the Company and the Guarantor entered into an Underwriting Agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC, Barclays Capital Inc., Citigroup Global Markets Inc. and SMBC Nikko Securities America, Inc., as representatives of the several Underwriters listed in Schedule 1 thereto.”